Evidence map›Paper›PMID 41778474›Full record

ReviewReproduction & fertility2026

The gap between prevalence of primary dysmenorrhea and available treatment strategies.

Laasya Koduri, Shivani Anandhasenthil, Lisa Zou, Annmarie Vilkins, Ripla Arora

Abstract readReview
In one paragraph

Review in Reproduction & fertility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laasya KoduriDepartment of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, East Lansing, Michigan, USA.
Shivani AnandhasenthilDepartment of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, East Lansing, Michigan, USA.
Lisa ZouDepartment of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, East Lansing, Michigan, USA.
Annmarie VilkinsHenry Ford Health, Department of Women's Health Services, Detroit, Michigan, USA.
Ripla AroraDepartment of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, East Lansing, Michigan, USA.ORCID 0000-0001-5051-6724

Funding

Signaling mechanisms that modulate uterine 3D structure for pregnancy successR01HD109152 · NICHD · MICHIGAN STATE UNIVERSITY · PI Ripla Arora · 2022 to 2026
$2.0M
NICHD NIH HHS R01 HD109152
6 · The paper itself

Abstract

Abstract: Primary dysmenorrhea is the cramping pain in the lower abdomen usually before or during menstruation. Although dysmenorrhea affects young girls and women of all ages, the etiology and treatment options are sparse and have limitations. Through a review of the existing literature, we document the history and elaborate on the mechanisms, diagnosis, and treatments related to dysmenorrhea. Based on cross-sectional studies, primary dysmenorrhea is a common issue affecting many women of reproductive age, often leading to absenteeism, and interfering with daily activities. Treatments such as non-steroidal anti-inflammatory drugs and oral contraceptives have been developed; however, they are not always effective, highlighting a gap between societal needs and available treatment options. To uncover the mechanisms underlying painful contractions, in vitro systems and animal models have been used, but they have limitations and do not fully replicate the condition, highlighting the gap between the prevalence of dysmenorrhea and our understanding of the etiology of dysmenorrhea and treatment options. A better understanding of the mechanisms that regulate uterine contractions through development of new model systems is needed to identify novel treatment approaches for dysmenorrhea. Lay summary: Primary dysmenorrhea or menstrual cramps are a common issue affecting many women of reproductive age, often leading to absenteeism, and interfering with daily activities. In our review, we highlight that treatments such as non-steroidal anti-inflammatory drugs and oral contraceptives have been developed; however, they are not always effective, highlighting a gap between societal needs and available treatment options. We also note that to uncover the mechanisms underlying painful contractions, in vitro systems and animal models have been used, but they have limitations and do not fully replicate the condition. Finally, we suggest that a better understanding of the mechanisms that regulate uterine contractions is needed to identify novel treatment approaches for dysmenorrhea.

Indexed as

DysmenorrheaAnimalsAnti-Inflammatory Agents, Non-SteroidalContraceptives, OralFemaleHumansPrevalenceAnti-Inflammatory Agents, Non-SteroidalContraceptives, Oraldysmenorrheanon-steroidal anti-inflammatory drugsoral contraceptive pillsoxytocinprostaglandin F2-alpha

Identifiers

PMID41778474
PMCPMC13011810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.